COPD exacerbation alert for patient stratification
This study evaluated the potential cost and effectiveness of RightStart testing (under development), which aims to guide treatment selections for COPD exacerbations in the primary care setting, using early-stage decision analytical modelling.
Is stratification testing for treatment of chronic obstructive pulmonary disease exacerbations cost-effective in primary care? An early cost-utility analysis.
Abel, L., H. A. Dakin, N. Roberts, H. F. Ashdown, C. C. Butler, G. Hayward, A. Van den Bruel, P. J. Turner and Y. Yang (2019).
International Journal of Technology Assessment in Health Care 35(2): 116-125.
Early economic evaluation of diagnostic technologies: experiences of the NIHR diagnostic evidence co-operatives.
Abel, L., B. Shinkins, A. Smith, A. J. Sutton, G. S. Sagoo, I. Uchegbu, A. J. Allen, S. Graziadio, E. Moloney and Y. Yang (2019).
Medical Decision Making 39(7): 857-866.
National Institute for Health Research Community Healthcare MedTech and In Vitro Diagnostics Co-operative
2018 – 2021